Lewiecki, E. M., Bilezikian, J. P., Clark, A., Collins, M. T., Kado, D. M., Lane, J., Langdahl, B., McClung, M. R., Snyder, P. J., & Stein, E. M. (2025). Proceedings of the 2024 Santa Fe Bone Symposium: Update on the Management of Osteoporosis and Rare Bone Diseases. Journal of Clinical Densitometry, 28(1), 101559. https://doi.org/10.1016/j.jocd.2024.101559

Yoel, U., Alkobi Weiss, H., Goldbart, A., Silverman Siris, E., Fisher, D. L., Hassan, L., & Fraenkel, M. (2024). The impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates—a single-center retrospective study. Osteoporosis International. https://doi.org/10.1007/s00198-024-07325-9

Bisikirska, B., Labella, R., Cuesta-Dominguez, A., Luo, N., De Angelis, J., Mosialou, I., Lin, C.-S., Beck, D., Lata, S., Shyu, P. T., McMahon, D. J., Guo, E., Hagen, J., Chung, W. K., Shane, E., Cohen, A., & Kousteni, S. (2024). Melatonin receptor 1A variants as genetic cause of idiopathic osteoporosis. Science Translational Medicine, 16(769). https://doi.org/10.1126/scitranslmed.adj0085

Cohen, A. (2024). Bone Metabolism, Bone Mass, and Bone Structure During Pregnancy and Lactation. Endocrinology and Metabolism Clinics of North America, 53(3), 453–470. https://doi.org/10.1016/j.ecl.2024.05.003

Jørgensen, H. S., Moe, S., & Nickolas, T. L. (2024). Diagnosis and therapeutic decisions of osteoporosis in chronic kidney disease. Journal of Bone and Mineral Research, 39(5), 531–535. https://doi.org/10.1093/jbmr/zjae062

Silva, B. C., Cusano, N. E., & Bilezikian, J. P. (2024). Primary hyperparathyroidism. Best Practice & Research Clinical Endocrinology & Metabolism, 38(1), 101247. https://doi.org/10.1016/j.beem.2018.09.013

Mohanty, S., Sardar, Z. M., Hassan, F. M., Lombardi, J. M., Lehman, R. A., & Lenke, L. G. (2023). Impact of Teriparatide on Complications and Patient-Reported Outcomes of Patients Undergoing Long Spinal Fusion According to Bone Density. Journal of Bone and Joint Surgery, 106(3), 206–217. https://doi.org/10.2106/jbjs.23.00272

Lewiecki, E. M., Bellido, T., Bilezikian, J. P., Brown, J. P., Farooki, A., Kovacs, C. S., Lee, B., Leslie, W. D., McClung, M. R., Prasarn, M. L., & Sellmeyer, D. E. (2023). Proceedings of the 2023 Santa Fe Bone Symposium: Progress and Controversies in the Management of Patients with Skeletal Diseases. Journal of Clinical Densitometry, 26(4), 101432. https://doi.org/10.1016/j.jocd.2023.101432

Kondapalli, A. V., Kamanda-Kosseh, M., Williams, J. M., Shiau, S., Bucovsky, M., Colon, I., Shane, E., & Cohen, A. (2023). Clinical characteristics of pregnancy and lactation associated osteoporosis: An online survey study. Osteoporosis International, 34(8), 1477–1489. https://doi.org/10.1007/s00198-023-06793-9

Ganapathy, A., Nieves, J. W., Keaveny, T. M., & Cosman, F. (2023). Effects of four-year cyclic versus two-year daily teriparatide treatment on volumetric bone density and bone strength in postmenopausal women with osteoporosis. Bone, 167, 116618. https://doi.org/10.1016/j.bone.2022.116618

Agarwal, S., Shiau, S., Kamanda-Kosseh, M., Bucovsky, M., Kil, N., Lappe, J. M., Stubby, J., Recker, R. R., Guo, X. E., Shane, E., & Cohen, A. (2020). Teriparatide Followed by Denosumab in Premenopausal Idiopathic Osteoporosis: Bone Microstructure and Strength by HR-pQCT. Journal of Bone and Mineral Research, 38(1), 35–47. https://doi.org/10.1002/jbmr.4739

Lewiecki, E. M., Bilezikian, J. P., Binkley, N., Bouxsein, M. L., Bukata, S. V., Dempster, D. W., Drake, M. T., McClung, M. R., Miller, P. D., Rosenthal, E., & Tosi, L. L. (2022). Proceedings of the 2022 Santa Fe Bone Symposium: Current Concepts in the Care of Patients with Osteoporosis and Metabolic Bone Diseases. Journal of Clinical Densitometry, 25(4), 649–667. https://doi.org/10.1016/j.jocd.2022.10.002

Bandeira, L., Silva, B. C., & Bilezikian, J. P. (2022). Male osteoporosis. Archives of Endocrinology and Metabolism, 66(5), 739–747. https://doi.org/10.20945/2359-3997000000563

Bandeira, F., Oliveira, L. B. de, & Bilezikian, J. P. (2022). Long-term consequences of osteoporosis therapy with denosumab. Archives of Endocrinology and Metabolism, 66(5), 717–723. https://doi.org/10.20945/2359-3997000000560

Kondapalli, A. V., & Walker, M. D. (2022). Celiac disease and bone. Archives of Endocrinology and Metabolism, 66(5), 756–764. https://doi.org/10.20945/2359-3997000000561

Cosman, F., Huang, S., McDermott, M., & Cummings, S. R. (2020). Multiple Vertebral Fractures After Denosumab Discontinuation: FREEDOM and FREEDOM Extension Trials Additional Post Hoc Analyses. Journal of Bone and Mineral Research, 37(11), 2112–2120. https://doi.org/10.1002/jbmr.4705

LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022). The clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis International, 33(10), 2049–2102. https://doi.org/10.1007/s00198-021-05900-y

Olali, A. Z., Carpenter, K. A., Myers, M., Sharma, A., Yin, M. T., Al-Harthi, L., & Ross, R. D. (2022). Bone Quality in Relation to HIV and Antiretroviral Drugs. Current HIV/AIDS Reports, 19(5), 312–327. https://doi.org/10.1007/s11904-022-00613-1

Goff, E., Cohen, A., Shane, E., Recker, R. R., Kuhn, G., & Müller, R. (2022). Large-scale osteocyte lacunar morphological analysis of transiliac bone in normal and osteoporotic premenopausal women. Bone, 160, 116424. https://doi.org/10.1016/j.bone.2022.116424

Agarwal, S., Shane, E., Lang, T., Shiau, S., Kamanda-Kosseh, M., Bucovsky, M., Lappe, J. M., Stubby, J., Recker, R. R., Hu, Y., Wang, Z., Edward Guo, X., & Cohen, A. (2022). Spine Volumetric BMD and Strength in Premenopausal Idiopathic Osteoporosis: Effect of Teriparatide Followed by Denosumab. The Journal of Clinical Endocrinology & Metabolism, 107(7), e2690–e2701. https://doi.org/10.1210/clinem/dgac232

Fusaro, M., Re Sartò, G. V., Gallieni, M., Cosmai, L., Messa, P., Rossini, M., Chiodini, I., Plebani, M., Evenepoel, P., Harvey, N., Ferrari, S., Cannata-Andía, J., Trombetti, A., Brandi, M. L., Ketteler, M., Nickolas, T. L., Cunningham, J., Salam, S., … Della Rocca, C. (2022). Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism. Nutrients, 14(9), 1742. https://doi.org/10.3390/nu14091742

Karsenty, G., & Khosla, S. (2022). The crosstalk between bone remodeling and energy metabolism: A translational perspective. Cell Metabolism, 34(6), 805–817. https://doi.org/10.1016/j.cmet.2022.04.010